Clinical Trial Update: A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of TAK-700 (orteronel) with leuprorelin acetate followed by surgery versus surgery alone in prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprorelin acetate (Leuprorelin acetate)
• TAK-700 (Orteronel)

Snippet

Sponsor: Centre of Experimental Medicine | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED